N. Bekele
- Hematology top 2%
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 2
- Genetics top 5%
- Glioma Diagnosis and Treatment 2
- Rheumatology top 5%
-
- CAR-T cell therapy research 2
- Cancer Treatment and Pharmacology 2
-
- Histone Deacetylase Inhibitors Research 3
-
- Hepatitis C virus research 3
-
- Brain Metastases and Treatment 2
- Co-authors
- Guillermo Garcia‐ManeroHagop M. KantarjianElias JabbourJörge E. CortesXian ZhouDan JonesRajyalakshmi LuthraSusan O’Brien
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- United StatesCanadaEthiopia
In The Last Decade
N. Bekele
22 papers receiving 994 citations
Peers
Comparison fields: 5 of 72
- Hematology 385
- Genetics 314
- Rheumatology 186
- Cancer Research 159
- Oncology 203
Countries citing papers authored by N. Bekele
This map shows the geographic impact of N. Bekele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Bekele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Bekele more than expected).
Fields of papers citing papers by N. Bekele
This network shows the impact of papers produced by N. Bekele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Bekele. The network helps show where N. Bekele may publish in the future.
Co-authorship network
The 25 scholars most cited alongside N. Bekele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2012 | 122 | |
| 3 | 2012 | 4 | |
| 4 | 2012 | 124 | |
| 5 | 2012 | 4 | |
| 6 | 2011 | 27 | |
| 7 | 2011 | 1 | |
| 8 | 2011 | 44 | |
| 9 | 2010 | 5 | |
| 10 | Vincristine in high-grade glioma. | 2010 | 8 |
| 11 | 2009 | 3 | |
| 12 | 2008 | 23 | |
| 13 | 2008 | 90 | |
| 14 | 2008 | 4 | |
| 15 | 2007 | 14 | |
| 16 | 2006 | 310 | |
| 17 | 2004 | 30 | |
| 18 | Increased Phospho-AKT (Ser473) Expression in Bronchial Dysplasia | 2003 | 2 |
| 19 | Alterations in the mitochondrial displacement loop in lung cancers. | 2003 | 90 |
| 20 | Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. | 2003 | 109 |
About N. Bekele
N. Bekele is a scholar working on Hematology, Hepatology and Genetics, having authored 23 papers that have together received 1.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Hepatitis C virus research (3 papers), CAR-T cell therapy research (2 papers), Glioma Diagnosis and Treatment (2 papers), Brain Metastases and Treatment (2 papers), Cancer Treatment and Pharmacology (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Hematology (385 citations), Genetics (314 citations) and Rheumatology (186 citations). N. Bekele has collaborated with scholars based in United States, Canada and Ethiopia. Frequent co-authors include Guillermo Garcia‐Manero, Hagop M. Kantarjian, Elias Jabbour, Jörge E. Cortes, Xian Zhou, Dan Jones, Rajyalakshmi Luthra, Susan O’Brien, Moshe Talpaz and Srđan Verstovšek. Their work appears in journals such as Journal of Clinical Oncology, Journal of Hepatology, Blood, Cancer and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.